The value of multi-country joint regulatory reviews: The experience of a WHO joint technical consultation on the CYD-TDV (Dengvaxia®) dossier

Affiliations

¹ World Health Organization, Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland.
² Dengue Vaccine Initiative - International Vaccine Institute, Seoul, South Korea.
³ Chair of Consultation, Paul Ehrlich Institut, Langen, Germany.
⁴ World Health Organization, Department of Essential Medicines, Geneva, Switzerland.
⁵ World Health Organization, Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland. Electronic address: hombachj@who.int.

Free article

Kirsten Vannice et al. Vaccine. 2017.

Free article

. 2017 Oct 13;35(43):5731-5733.

doi: 10.1016/j.vaccine.2017.07.044. Epub 2017 Jul 26.

¹ World Health Organization, Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland.
² Dengue Vaccine Initiative - International Vaccine Institute, Seoul, South Korea.
³ Chair of Consultation, Paul Ehrlich Institut, Langen, Germany.
⁴ World Health Organization, Department of Essential Medicines, Geneva, Switzerland.
⁵ World Health Organization, Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland. Electronic address: hombachj@who.int.

No abstract available

Keywords: Dengue vaccine; Joint review; Vaccine; Vaccine regulation.

MeSH terms